[177Lu-PSMA therapy : Current evidence for use in the treatment of patients with metastatic prostate cancer].
about
[177Lu-PSMA therapy : Current evidence for use in the treatment of patients with metastatic prostate cancer].
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
[177Lu-PSMA therapy : Current ...... h metastatic prostate cancer].
@en
[177Lu-PSMA therapy : Current ...... h metastatic prostate cancer].
@nl
type
label
[177Lu-PSMA therapy : Current ...... h metastatic prostate cancer].
@en
[177Lu-PSMA therapy : Current ...... h metastatic prostate cancer].
@nl
prefLabel
[177Lu-PSMA therapy : Current ...... h metastatic prostate cancer].
@en
[177Lu-PSMA therapy : Current ...... h metastatic prostate cancer].
@nl
P2860
P1433
P1476
[177Lu-PSMA therapy : Current ...... h metastatic prostate cancer].
@en
P2093
A J Schrader
M Boegemann
P2860
P304
P356
10.1007/S00120-017-0510-5
P407
P577
2017-10-06T00:00:00Z